Cited by 272Pluripotent Stem Cells ResearchTissue Engineering and Regenerative MedicineCongenital heart defects research

Differentiation of cardiomyocytes and generation of human engineered heart tissue

Breckwoldt, Kaja, Letuffe-Brenière, David, Mannhardt, Ingra, Schulze, Thomas, Ulmer, Bärbel, Werner, Tessa, Benzin, Anika, Klampe, Birgit +14 more·2017·Nature Protocols

Abstract

Since the advent of the generation of human induced pluripotent stem cells (hiPSCs), numerous protocols have been developed to differentiate hiPSCs into cardiomyocytes and then subsequently assess their ability to recapitulate the properties of adult human cardiomyocytes. However, hiPSC-derived cardiomyocytes (hiPSC-CMs) are often assessed in single-cell assays. A shortcoming of these assays is the limited ability to characterize the physiological parameters of cardiomyocytes, such as contractile force, due to random orientations. This protocol describes the differentiation of cardiomyocytes from hiPSCs, which occurs within 14 d. After casting, cardiomyocytes undergo 3D assembly. This produces fibrin-based engineered heart tissues (EHTs)-in a strip format-that generate force under auxotonic stretch conditions. 10-15 d after casting, the EHTs can be used for contractility measurements. This protocol describes parallel expansion of hiPSCs; standardized generation of defined embryoid bodies, growth factor and small-molecule-based cardiac differentiation; and standardized generation of EHTs. To carry out the protocol, experience in advanced cell culture techniques is required.

Integrity signals

Registry

Crossref · 10.1038/nprot.2017.033

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Optimal cardiogenic mesoderm induction for all hESC and hiPSC lines was found at 1-4 μM CHIR99021 concentrations, rather than the typical 10-12 μM range reported for monolayer methods.

    “Optimal cardiogenic mesoderm induction for all human embryonic stem cell (hESC) and induced pluripotent stem cell (hiPSC) lines was found at 1–4 μM CHIR99021 concentrations, rather than the typical 10–12 µM range reported for monolayer methods14,21–27.”
  • BMP4 and Activin A induce cardiac mesoderm in the embryo, and established differentiation protocols using them differentiate to various cardiac mesoderm progenitors.

    “These growth factors lead to the induction of cardiac mesoderm in the embryo70 and established differentiation protocols using them show effective differentiation to various cardiac mesoderm progenitors23,70,71.”

Cites

Flagged first, then by citations

1 of the 60 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Breckwoldt, K., Letuffe-Brenière, D., Mannhardt, I., Schulze, T., Ulmer, B., Werner, T., Benzin, A., Klampe, B., Reinsch, M. C., Laufer, S., Shibamiya, A., Prondzynski, M., Mearini, G., Schade, D., Fuchs, S., Neuber, C., Krämer, E., Saleem, U., Schulze, M. L., Rodriguez, M. L., Eschenhagen, T., & Hansen, A.
Affiliations
  • University Medical Center Hamburg-Eppendorf (DE)
  • TU Dortmund University (DE)
Corresponding author
Hansen, Arne
Venue
Nature Protocols
Published
2017-05-11
Volume
12
Issue
6
Pages
1177-1197
ISSN
  • 1750-2799 (ISSN-L)
  • 1754-2189
OpenAlex
W2612983729
Cited by
272
References
60
Citations by year
2026: 23 · 2025: 33 · 2024: 26 · 2023: 20 · 2022: 35 · 2021: 41 · 2020: 40 · 2019: 28 · 2018: 18 · 2017: 8
FWCI
10.49
Type
journal article
Language
en
Open access
closed
Locations
  • Nature Protocols (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
Keywords
cardiomyocyte differentiation, human induced pluripotent stem cells, engineered heart tissue, cardiomyocyte contractility, embryoid bodies, cardiac differentiation
MeSH terms
Cell Differentiation, Humans, Tissue Engineering, Myocytes, Cardiac, Induced Pluripotent Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review